Nitrous Oxide for Treatment-Resistant Depression

NMDA Receptor Antagonist Nitrous Oxide Targets Affective Brain Circuits

Recruiting Phase 1 Interventional Study
Depressive Disorder, Major Depressive Disorder, Treatment-Resistant
Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 65
Sex
Any
Trial phase
Phase 1
Study type
Interventional
Purpose
Treatment
Participants needed
60 (estimated)
Sponsor
Washington University School of Medicine · Other
Who this trial is looking for

This trial is looking for adults with treatment-resistant major depression and healthy adults without depression. Participants will inhale nitrous oxide or a placebo and have their brain activity monitored to better understand how this treatment works.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am between 18 and 65 years old.
  • I am right-handed.
  • I score 17 or more on the Hamilton Depression Rating Scale.
  • I have had at least 3-4 treatments for depression that did not work.
  • I have a good command of the English language.

You may not be able to join if

  • I have any major mental health diagnosis other than depression.
  • I have a neurological or serious medical disorder.
  • I am currently taking any medication that affects the brain.
  • I am left-handed.
  • I am not eligible for MRI scans.
  • I have a recent history of substance dependence or abuse.
  • I am able to become pregnant and not using effective contraception.
  • I cannot provide informed consent.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
Most clinical major depression responds to standard treatments (medication and psychotherapy); however, a significant subset of depressed patients (15-20%) do not respond to these treatments and are referred to as treatment-resistant major depression (TRMD). New treatments for TRMD are needed, and one promising line of research are drugs known as N-methyl-D-aspartate (NMDA) glutamate receptor anta…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adults 18-65 years of age * Right-handed * Controls: Not meet The Fourth Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria for major depressive disorder (MDD) by scoring ≤7 on the Hamilton Depression Rating Scale (HDRS), 17-item; Treatment-…
Contacts

Britt Gott, MS

314-362-2463

gottb@wustl.edu

CONTACT

Anvita Vishwanath, BS

314-273-1921

a.vishwanath@wustl.edu

CONTACT